|
Re: Hepa...
|
1
|
Resverlogix Corp.
|
Dec 05, 2019 05:11PM
|
|
Re: Heart failure study
|
1
|
Resverlogix Corp.
|
Feb 09, 2021 01:46PM
|
|
Re: Heart failure study
|
1
|
Resverlogix Corp.
|
Feb 09, 2021 02:52PM
|
|
Re: H1 2020 Potential Events -- NFK goes Virtual
|
1
|
Resverlogix Corp.
|
Mar 10, 2020 01:33PM
|
|
Re: H1 2020 Potential Events
|
1
|
Resverlogix Corp.
|
Mar 09, 2020 12:52PM
|
|
Re: Ground Hog Day
|
10
|
Resverlogix Corp.
|
Sep 18, 2020 03:20PM
|
|
Re: Gran Oso....
|
9
|
Resverlogix Corp.
|
Dec 20, 2019 10:07AM
|
|
Re: Got back from IR
|
2
|
Resverlogix Corp.
|
May 02, 2020 01:00PM
|
|
Re: Gilead pays $21B for Immunomedics, a single cancer drug (newly approved) for metastic Triple Negative Breast Cancer
|
1
|
Zenith Epigenetics
|
Sep 24, 2020 11:03AM
|
|
Re: from J4P on SH “ "I will go out on a limb with a prediction, but please follow my line of reasoning”
|
1
|
Resverlogix Corp.
|
Mar 05, 2021 01:57PM
|
|
Re: Flavoured HIV drug for children to be rolled out in Africa?
|
1
|
Resverlogix Corp.
|
Dec 02, 2020 09:50AM
|
|
Re: Flavoured HIV drug for children to be rolled out in Africa?
|
|
Resverlogix Corp.
|
Dec 02, 2020 10:21AM
|
|
Re: Flavoured HIV drug for children to be rolled out in Africa?
|
3
|
Resverlogix Corp.
|
Dec 02, 2020 10:37AM
|
|
Re: Flavoured HIV drug for children to be rolled out in Africa?
|
1
|
Resverlogix Corp.
|
Dec 02, 2020 01:08PM
|
|
Re: Fireside Chat
|
10
|
Resverlogix Corp.
|
Oct 11, 2020 10:18AM
|
|
Re: Fireside Chat
|
3
|
Resverlogix Corp.
|
Oct 11, 2020 02:00PM
|
|
Re: Financei
|
2
|
Resverlogix Corp.
|
Feb 05, 2020 07:24AM
|
|
Re: Finance
|
5
|
Resverlogix Corp.
|
Jul 01, 2020 01:01PM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
Aug 06, 2020 01:38PM
|
|
Re: Finance
|
3
|
Resverlogix Corp.
|
Feb 10, 2021 10:46AM
|
